Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,797Revenue (TTM) $M1,338Net Margin (%)6.0Altman Z-Score3.4
Enterprise Value $M7,333EPS (TTM) $0.3Operating Margin %7.4Piotroski F-Score4
P/E(ttm)88.5Beneish M-Score-2.8Pre-tax Margin (%)4.3Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %2.9Quick Ratio2.9Cash flow > EarningsY
Price/Sales5.25-y EBITDA Growth Rate %1.9Current Ratio3.4Lower Leverage y-yN
Price/Free Cash Flow27.9y-y EBITDA Growth Rate %-15.5ROA % (ttm)1.9Higher Current Ratio y-yN
Dividend Yield %--PEG46.6ROE % (ttm)3.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M226ROIC % (ttm)2.8Gross Margin Increase y-yN

Gurus Latest Trades with QGEN

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

QGEN is held by these investors:



QGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about QGEN :

Quarterly/Annual Reports about QGEN:

    News about QGEN:

    Articles On GuruFocus.com
    New Research Suggests Potential for Additional Clinical Utility of QIAGEN's QuantiFERON-TB Gold Plus Apr 12 2017 
    QIAGEN Posts 2016 Annual Report on its Website Apr 06 2017 
    QIAGEN N.V. to Report First Quarter 2017 Results Apr 06 2017 
    QIAGEN's GeneReader NGS System Gains Further Validation in Oncology Research Applications With New I Apr 03 2017 
    QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer Mar 31 2017 
    QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows Mar 31 2017 
    QIAGEN Launches First FDA-cleared JAK2 Test for Certain Type of Leukemia Mar 31 2017 
    David Herro's Oakmark International Small Cap Fund 4th Quarter Commentary Jan 08 2016 
    Seegene and QIAGEN Enter Into a Collaboration to Develop Multiplex Molecular Diagnostic Assays Jul 08 2015 
    Biotech Gets Personal: Long on Qiagen (QGEN) & SPDR S&P Biotech (XBI) Feb 29 2012 

    More From Other Websites
    QIAGEN NV – Value Analysis (NASDAQ:QGEN) : April 26, 2017 Apr 26 2017
    QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : April 25, 2017 Apr 25 2017
    The Top Gene-Sequencing Stock to Buy in 2017 Apr 20 2017
    New Research Suggests Potential for Additional Clinical Utility of QIAGEN's QuantiFERON-TB Gold Plus Apr 12 2017
    Qiagen (QGEN) Down 2.6% Since Earnings Report: Can It Rebound? Apr 12 2017
    QIAGEN Posts 2016 Annual Report on its Website Apr 06 2017
    QIAGEN N.V. to Report First Quarter 2017 Results Apr 06 2017
    QIAGEN Releases Favorable GeneReader Results, Expands in NGS Apr 04 2017
    QIAGEN's GeneReader NGS System Gains Further Validation in Oncology Research Applications With New... Apr 03 2017
    QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer Mar 31 2017
    QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows Mar 30 2017
    QIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics Mar 30 2017
    QIAGEN Launches First FDA-cleared JAK2 Test for Certain Type of Leukemia Mar 29 2017
    QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : March 28, 2017 Mar 28 2017
    New Study Published in Lancet Respiratory Medicine Highlights QIAGEN's QuantiFERON-TB Potential to... Feb 16 2017
    QIAGEN NV :QGEN-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017 Feb 08 2017
    QIAGEN (QGEN) Earnings Meet, Sales Miss Estimates in Q4 Feb 03 2017
    Edited Transcript of QGEN earnings conference call or presentation 2-Feb-17 2:00pm GMT Feb 02 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)